First-Generation Drug-Eluting Stents… and Beyond

被引：0
|
作者：
William Wijns
机构：
[1] Cardiovascular Center Aalst,
来源：
Drug Safety | 2009年 / 32卷
关键词：
Dual Antiplatelet Therapy; Late Stent Thrombosis; Rare Adverse Effect; Delay Hypersensitivity Reaction; Repeat Angiography;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：771 / 773
页数：2
相关论文
共 50 条
  • [41] Comparison of clinical outcomes between first-generation and second-generation drug-eluting stents in type 2 diabetic patients
    Jeong, Han Saem
    Cho, Jae Young
    Kim, Eun Ji
    Yu, Cheol Woong
    Ahn, Chul-Min
    Park, Jae Hyoung
    Hong, Soon Jun
    Lim, Do-Sun
    CORONARY ARTERY DISEASE, 2013, 24 (08) : 676 - 683
  • [42] Safety and Efficacy of the XIENCE V Everolimus-Eluting Stent Compared to First-Generation Drug-Eluting Stents in Contemporary Clinical Practice
    Waksman, Ron
    Barbash, Israel M.
    Dvir, Danny
    Torguson, Rebecca
    Ben-Dor, Itsik
    Maluenda, Gabriel
    Xue, Zhenyi
    Satler, Lowell F.
    Suddath, William O.
    Kent, Kenneth M.
    Pichard, Augusto D.
    AMERICAN JOURNAL OF CARDIOLOGY, 2012, 109 (09): : 1288 - 1294
  • [43] Clinical Impact of Second-Generation Everolimus-Eluting Stents Compared With First-Generation Drug-Eluting Stents in Diabetic Patients Undergoing Multivessel Percutaneous Coronary Intervention
    Pendyala, Lakshmana
    Loh, Joshua
    Kitabata, Hironori
    Minha, Sa'ar
    Chen, Fang
    Torguson, Rebecca
    Suddath, William
    Satler, Lowell
    Pichard, Augusto
    Waksman, Ron
    JOURNAL OF INVASIVE CARDIOLOGY, 2015, 27 (06): : 263 - 268
  • [44] CLINICAL IMPACT OF SECOND-GENERATION EVEROLIMUS-ELUTING STENTS COMPARED WITH FIRST-GENERATION DRUG-ELUTING STENTS IN DIABETIC PATIENTS UNDERGOING MULTIVESSEL PERCUTANEOUS CORONARY INTERVENTION
    Pendyala, Lakshmana
    Loh, Joshua
    Torguson, Rebecca
    Satler, Lowell
    Minha, Sa'ar
    Baker, Nevin
    Alarcon, Ricardo Escarcega
    Ota, Hideaki
    Pichard, Augusto
    Waksman, Ron
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (12) : A1909 - A1909
  • [45] Drug-Eluting Stents and Diabetes: A Generation Gap?
    Parikh, Pragnesh P.
    Levy, Michael S.
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2013, 81 (07) : 1115 - 1116
  • [46] Efficacy and safety of everolimus and zotarolimus-eluting stents versus first-generation drug-eluting stents in patients with diabetes: A meta-analysis of randomized trials
    Bavishi, Chirag
    Baber, Usman
    Panwar, Sadik
    Pirrotta, Stefania
    Dangas, George D.
    Moreno, Pedro
    Tamis-Holland, Jacqueline
    Kini, Annapoorna S.
    Sharma, Samin K.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 230 : 310 - 318
  • [47] Outcome of stent thrombosis following second-versus first-generation drug-eluting stents: it is time to SORT OUT!
    Nammas, Wail
    CORSALUD, 2015, 7 (01): : 89 - 90
  • [48] Major Adverse Cardiac Events in Patients With Moderate to Severe Renal Insufficiency Treated With First-Generation Drug-Eluting Stents
    Sukhija, Rishi
    Aronow, Wilbert S.
    Palaniswamy, Chandrasekar
    Singh, Tarunjit
    Sukhija, Rashmi
    Kalapatapu, Kumar
    Mohan, Diwakar
    Pucillo, Anthony L.
    Sorbera, Carmine
    Kakar, Priyanka
    Weiss, Melvin B.
    Lal, Purshotam
    Monsen, Craig E.
    AMERICAN JOURNAL OF CARDIOLOGY, 2010, 105 (03): : 293 - 296
  • [49] Domestic New-generation Drug-eluting Stents Versus Imported New-generation Drug-eluting Stents in China
    Liu, Ru
    Gao, Zhan
    Ma Yuanliang
    Song, Ying
    Wang, Huanhuan
    Jiang, Lin
    Gao, Lijian
    Qiao, Shubin
    Yang, Yuejin
    Gao, Runlin
    Xu, Bo
    Yuan, Jinqing
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (15) : S69 - S70
  • [50] Pathology of second- versus first-generation drug-eluting stents in humans: does safety issue still exist?
    Otsuka, F.
    Nakano, M.
    Vorpahl, M.
    Yazdani, S. K.
    Ladich, E.
    Kolodgie, F. D.
    Finn, A. V.
    Virmani, R.
    EUROPEAN HEART JOURNAL, 2011, 32 : 82 - 82
12345